All Stories

  1. Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

    Article • Liver International, January 2018, Wiley

    Professor Giovanni Squadrito

  2. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

    Article • Alimentary Pharmacology & Therapeutics, August 2017, Wiley

    Dr GIUSEPPE CABIBBO, Professor Giovanni Squadrito

  3. Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series

    Article • British Journal of Clinical Pharmacology, January 2017, Wiley

    Professor Giovanni Squadrito

  4. Atrial fibrillation in patients with cirrhosis

    Article • Liver International, September 2015, Wiley

    Professor Giovanni Squadrito

  5. Case Report

    Article • Medicine, September 2015, Wolters Kluwer Health

    Professor Giovanni Squadrito